NOVEL ORALLY ADMINISTERED DOSAGE FORM FOR 3-[(2-{[4-(HEXYLOXYCARBONYLAMINO-IMINO-METHYL)-PHENYLAMINO]-METHYL}-1-METHYL-1H-BENZIMIDAZOL-5-CARBONYL)-PYRIDIN-2-YL-AMINO]-ETHYL PROPRIONATE AND SALTS THEREOF
摘要
申请公布号
EP1663209(A1)
申请公布日期
2006.06.07
申请号
EP20040764593
申请日期
2004.08.28
申请人
BOEHRINGER INGELHEIM INTERNATIONAL GMBH;BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG
